7773-69-5 Usage
General Description
4-Benzylpiperazine-1-carboxamidine hemisulfate is a chemical compound that is commonly used in research and testing procedures. It is a hemisulfate salt derivative of the molecular compound benzylpiperazine, which is known for its psychoactive properties. The carboxamidine group attached to the piperazine ring enhances its pharmacological and biological activities, making it a valuable tool in medicinal chemistry studies. 4-BENZYLPIPERAZINE-1-CARBOXAMIDINE HEMISULFATE has been studied for its potential in treating various neurological disorders and as a precursor for the synthesis of new drug candidates. Its hemisulfate form enhances its solubility and stability, making it a versatile and valuable tool in scientific research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 7773-69-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,7 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7773-69:
(6*7)+(5*7)+(4*7)+(3*3)+(2*6)+(1*9)=135
135 % 10 = 5
So 7773-69-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N4/c13-12(14)16-8-6-15(7-9-16)10-11-4-2-1-3-5-11/h1-5H,6-10H2,(H3,13,14)
7773-69-5Relevant articles and documents
Synthesis and antitumor activities of a new series of 4,5-dihydro-1H- thiochromeno[4,3-d]pyrimidine derivatives
Guo, Dexiang,Liu, Yajing,Li, Ting,Wang, Nan,Zhai, Xin,Hu, Chun,Gong, Ping
experimental part, p. 347 - 351 (2012/08/08)
A new series of 4,5-dihydro-1H-thiochromeno[4,3-d ]pyrimidine derivatives have been designed and synthesized. The antitumor activities of the target compounds have been evaluated in vitro against two human cancer cell lines including A549 (human alveolar adenocarcinoma cell) and H460 (human lung cancer) by MTT assay. Most of the target compounds exhibited significant antitumor activities against A549 and H460 cancer cell lines. The most potent compound 4-(benzo[d][1,3]dioxol-5-yl)-8,9-difluoro-2-(4-methylpiperazin-1-yl)-4, 5-dihydro-1H-thiochromeno[4,3-d]pyrimidine (CH05) (IC50 = 0.44 μM, 3.07 μM) was 2.0 and 8.4 times more active than gefitinib (IC50 = 0.89 μM, 16.81 μM) against A549 and H460 cell lines, respectively.